3 Reasons Hep C Premiums Might Not Last
Motley Fool
Roche: New Era Of Hepatitis Therapies Creates Short-Term Threat, Long-Term Opportunity
Seeking Alpha
Hep C Drug Updates: Vertex and Anadys
TheStreet.com
12 Cancer Stocks Being Snapped Up by Insiders
Seeking Alpha
News
Yahoo/PR NewsWire

